{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:51:41Z","timestamp":1781124701781,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["S10OD023527"],"award-info":[{"award-number":["S10OD023527"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["SCR_022039"],"award-info":[{"award-number":["SCR_022039"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["MBGI-23-1030244-01-MBG"],"award-info":[{"award-number":["MBGI-23-1030244-01-MBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD023527"],"award-info":[{"award-number":["S10OD023527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R01 CA253615"],"award-info":[{"award-number":["R01 CA253615"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R01 CA274640"],"award-info":[{"award-number":["R01 CA274640"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["75N91010D00024"],"award-info":[{"award-number":["75N91010D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.toxrep.2025.102022","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:35:57Z","timestamp":1744122957000},"page":"102022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus \u2013 A cancer immunotherapy candidate"],"prefix":"10.1016","volume":"14","author":[{"given":"Stephan T.","family":"Stern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Fernanda","family":"Affonso de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Gatus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry W.","family":"Neun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Dobrovolskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-0481","authenticated-orcid":false,"given":"Nicole F.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1984677","article-title":"Trial watch: intratumoral immunotherapy","volume":"10","author":"Humeau","year":"2021","journal-title":"Oncoimmunology"},{"issue":"7378","key":"10.1016\/j.toxrep.2025.102022_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102022_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"25","key":"10.1016\/j.toxrep.2025.102022_bib4","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.toxrep.2025.102022_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090982","article-title":"Monocytes exposed to immune complexes reduce pDC type 1 interferon response to vidutolimod","volume":"9","author":"Sabree","year":"2021","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.toxrep.2025.102022_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s44222-024-00231-z","article-title":"Virus nanotechnology for intratumoural immunotherapy","volume":"2","author":"Omole","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102022_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nnano.2015.292","article-title":"In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer","volume":"11","author":"Lizotte","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"10.1016\/j.toxrep.2025.102022_bib8","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1021\/acs.nanolett.2c01328","article-title":"Cowpea mosaic virus and natural killer cell agonism for in situ cancer vaccination","volume":"22","author":"Koellhoffer","year":"2022","journal-title":"Nano Lett."},{"issue":"27","key":"10.1016\/j.toxrep.2025.102022_bib9","doi-asserted-by":"crossref","first-page":"2002299","DOI":"10.1002\/adfm.202002299","article-title":"A combination of cowpea mosaic virus and immune checkpoint therapy synergistically improves therapeutic efficacy in three tumor models","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.toxrep.2025.102022_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120914","article-title":"Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors","volume":"275","author":"Mao","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.toxrep.2025.102022_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005834","article-title":"In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade","volume":"10","author":"Mao","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"19","key":"10.1016\/j.toxrep.2025.102022_bib12","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1039\/D0BM01219J","article-title":"The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine","volume":"8","author":"Shukla","year":"2020","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102022_bib13","article-title":"Cowpea mosaic virus promotes anti-tumor activity and immune memory in a mouse ovarian tumor model","volume":"2","author":"Wang","year":"2019","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102022_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004044","article-title":"Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer","volume":"10","author":"Alonso-Miguel","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.toxrep.2025.102022_bib15","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/acs.molpharmaceut.8b00126","article-title":"Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation","volume":"15","author":"Hoopes","year":"2018","journal-title":"Mol. Pharm."},{"issue":"18","key":"10.1016\/j.toxrep.2025.102022_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182241","article-title":"Neoadjuvant intratumoral immunotherapy with cowpea mosaic virus induces local and systemic antitumor efficacy in canine mammary cancer patients","volume":"12","author":"Valdivia","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1999.0038","article-title":"The refined crystal structure of cowpea mosaic virus at 2.8 A resolution","volume":"265","author":"Lin","year":"1999","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102022_bib18","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/acsnano.9b07865","article-title":"Antibody response against cowpea mosaic viral nanoparticles improves in situ vaccine efficacy in ovarian cancer","volume":"14","author":"Shukla","year":"2020","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102022_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00262-024-03636-2","article-title":"Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade","volume":"73","author":"Karan","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102022_bib20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/j.1460-2075.1983.tb01731.x","article-title":"The nucleotide sequence of cowpea mosaic virus B RNA","volume":"2","author":"Lomonossoff","year":"1983","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102022_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/j.1460-2075.1983.tb01525.x","article-title":"Primary structure and gene organization of the middle-component RNA of cowpea mosaic virus","volume":"2","author":"van Wezenbeek","year":"1983","journal-title":"EMBO J."},{"key":"10.1016\/j.toxrep.2025.102022_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-3527(03)62004-X","article-title":"Structures of picorna-like plant viruses: implications and applications","volume":"62","author":"Lin","year":"2003","journal-title":"Adv. Virus Res"},{"key":"10.1016\/j.toxrep.2025.102022_bib23","series-title":"Encyclopaedia of Virology","article-title":"Comoviruses (Comoviridae)","author":"Lomonossoff","year":"1999"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s42003-024-06982-0","article-title":"Cellular fate of a plant virus immunotherapy candidate","volume":"7","author":"Omole","year":"2024","journal-title":"Commun. Biol."},{"issue":"1-2","key":"10.1016\/j.toxrep.2025.102022_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2007.04.003","article-title":"Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo","volume":"120","author":"Singh","year":"2007","journal-title":"J. Control Release"},{"key":"10.1016\/j.toxrep.2025.102022_bib26","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c06143","article-title":"In vivo fate of cowpea mosaic virus in situ vaccine: biodistribution and clearance","author":"Affonso de Oliveira","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.toxrep.2025.102022_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4939-9516-5_10","article-title":"In situ vaccination of tumors using plant viral nanoparticles","author":"Murray","year":"2019","journal-title":"Methods Mol. Biol. 2000"},{"issue":"11","key":"10.1016\/j.toxrep.2025.102022_bib28","doi-asserted-by":"crossref","first-page":"18315","DOI":"10.1021\/acsnano.2c06143","article-title":"In vivo fate of cowpea mosaic virus in situ vaccine: biodistribution and clearance","volume":"16","author":"Affonso de Oliveira","year":"2022","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.toxrep.2025.102022_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10693","article-title":"Cowpea mosaic virus intratumoral immunotherapy maintains stability and efficacy after long-term storage","volume":"9","author":"Simms","year":"2024","journal-title":"Bioeng. Transl. Med"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/viru.26083","article-title":"Animal models of sepsis","volume":"5","author":"Fink","year":"2014","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.toxrep.2025.102022_bib31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI117554","article-title":"Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats","volume":"94","author":"Chang","year":"1994","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib32","first-page":"89","article-title":"Comparison of plasma endotoxin levels in germ-free, SPF and conventional laboratory animals (mice and rats)","volume":"42","author":"Sugiyama","year":"1993","journal-title":"Jikken Dobutsu"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102022_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","article-title":"The endotoxin hypothesis of neurodegeneration","volume":"16","author":"Brown","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"15","key":"10.1016\/j.toxrep.2025.102022_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25153367","article-title":"Detection of beta-glucan contamination in nanotechnology-based formulations","volume":"25","author":"Neun","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102022_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0300985811415701","article-title":"Appropriate use of recovery groups in nonclinical toxicity studies: value in a science-driven case-by-case approach","volume":"49","author":"Pandher","year":"2012","journal-title":"Vet. Pathol."},{"issue":"8","key":"10.1016\/j.toxrep.2025.102022_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801288","article-title":"CD47 blockade and cowpea mosaic virus nanoparticle in situ vaccination triggers phagocytosis and tumor killing","volume":"8","author":"Wang","year":"2019","journal-title":"Adv. Health Mater."},{"issue":"21","key":"10.1016\/j.toxrep.2025.102022_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00129-19","article-title":"Cowpea mosaic virus nanoparticles and empty virus-like particles show distinct but overlapping immunostimulatory properties","volume":"93","author":"Wang","year":"2019","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.toxrep.2025.102022_bib38","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.8b00316","article-title":"In situ vaccination with cowpea vs tobacco mosaic virus against melanoma","volume":"15","author":"Murray","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.toxrep.2025.102022_bib39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2021.08.048","article-title":"Complement opsonization of nanoparticles: differences between humans and preclinical species","volume":"338","author":"Li","year":"2021","journal-title":"J. Control Release"}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:44:19Z","timestamp":1778863459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S2214750025001404"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102022","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus \u2013 A cancer immunotherapy candidate","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102022"}}